全球生命科學和分析儀器市場 - 市場規模、佔有率、成長分析：按技術（NGS、PCR）、按用途（研究用途、臨床/診斷用途） - 行業預測（2023-2030）

Global Life Sciences and Analytical Instruments Market Size, Share, Growth Analysis, By Technology(NGS, PCR), By Application(Research applications and Clinical & diagnostic applications) - Industry Forecast 2023-2030

出版日期: 2023年06月05日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年生命科學和分析儀器市場規模為714億美元。預測該市場在預測期內（2023-2030年）將以7%的年複合成長率擴張，從2022年的765.6億美元成長到2030年的1304.7億美元。

生命科學和分析儀器應用於各個領域，包括實驗室、醫院、診所、生物技術和製藥公司。其用處在於對最終產品和原料進行檢驗和檢驗。這些工具對於確保商品的品質和安全至關重要，可以在各個行業進行準確評估，同時防止潛在危險。

從地區來看，全球生命科學和分析儀器市場涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。值得注意的是，北美地區佔據壓倒性地位，2022 年約佔市場收入的 38%。醫藥研發投入不斷增加，行業龍頭企業前景看好。此外，對產品完整性法規力度的加強正在加速食品和飲料行業的採用。在德國的帶領下，歐洲在藥物研究和技術進步方面蓬勃發展。在印度和中國的強勁擴張以及製藥行業的進步的推動下，亞太地區呈現出強勁的成長勢頭。

生物技術和製藥等行業投入了大量資源用於研發 (R&D)。其目的是加快藥物研發並促進針對罕見疾病的創新療法的推出。國際藥品製造商協會聯合會（IFPMA）報告稱，製藥行業每年的研發投資超過1500億美元。已開發出7000多種新化合物，56種新藥正在開發中。快速有效的生命科學工具在加速藥物開發方面發揮著至關重要的作用，特別是針對心血管疾病、神經系統疾病、癌症和感染疾病，推動了全球生命科學和分析儀器市場的發展。

生命科學和分析儀器領域擴張的潛在要素包括設備成本急劇上升、公眾健康意識下降以及可行替代方案的可用性。由於成本上升限制了採用、足夠的認知限制了需求，以及可行替代方案的存在可能會驅使投資和興趣遠離傳統生命科學和分析儀器，該行業的成長軌跡可能會受到這些要素的限制。

該報告審視了全球生命科學和分析儀器市場，提供了市場概述、技術趨勢、用途、地區以及參與市場的公司概況。

主要企業簡介
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- PerkinElmer Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- Merck KGaA
- GE Healthcare
- bioMerieux SA
- Hitachi High-Technologies Corporation
- Bio-Rad Laboratories Inc.
- Olympus Corporation
- Beckman Coulter Inc.
- Eppendorf AG
- Illumina Inc.
- Qiagen NV
- Becton, Dickinson and Company
- Hologic Inc.
- Sartorius AG

簡介目錄

Product Code: SQMIG35G2112

Life Sciences and Analytical Instruments Market size was valued at USD 71.4 billion in 2021 and is poised to grow from USD 76.56 billion in 2022 to USD 130.47 billion by 2030, growing at a CAGR of 7% in the forecast period (2023-2030).

Life science and analytical instruments find applications across diverse sectors such as laboratories, hospitals, clinics, as well as biotechnology and pharmaceutical companies. Their utility lies in the examination and validation of both end products and raw materials. These tools are pivotal in ensuring the quality and safety of goods, enabling precise evaluations in various industries while safeguarding against potential hazards. Global life sciences and analytical instruments market is segmented on the basis of technology, application and region. On the basis of Technology, global market is segmented into Spectroscopy, PCR, Next-Generation Sequencing (NGS), Microscopy, Flow Cytometry and Chromatography. On the basis of application, global market is segmented into research applications and clinical & diagnostic applications. On the basis of region, global market is divided into North America, Europe, Asia-Pacific, Latin America, and MEA.

Segmented by geography, the global market for life sciences and analytical instruments spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Notably, North America emerged as the dominant player, constituting approximately 38% of the market's revenue in 2022. Heightened investments in pharmaceutical R&D offer prospects for industry leaders. Additionally, escalated regulatory scrutiny regarding product integrity fuels adoption within the food and beverage sector. Europe, led by Germany, thrives on pharmaceutical research and technological strides. Asia-Pacific, driven by dynamic expansions in India and China, showcases robust growth attributed to advancing pharmaceutical industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Sciences and Analytical Instruments Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Driver:

Industries like biotechnology and pharmaceuticals are committing substantial resources to research and development (R&D) endeavors. This is aimed at expediting drug discovery and facilitating the innovative launch of therapeutic agents targeting rare ailments. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reports an annual R&D investment exceeding US$ 150 billion within the pharmaceutical sector. Over 7,000 novel compounds have been formulated, introducing 56 new drugs. Swift and effective life science tools play a pivotal role in hastening drug development, particularly for conditions such as cardiovascular diseases, neurological disorders, cancer, and infectious diseases, thereby propelling the global life sciences and analytical instruments market.

Restraint:

Anticipated impediments to the expansion of the life science and analytical equipment sector encompass escalating instrument expenditures, limited public health awareness, and the presence of feasible alternative options. The industry's growth trajectory might be constrained by these factors, as higher costs could deter adoption, insufficient awareness might limit demand, and the existence of viable alternatives could divert investment and interest away from traditional life science and analytical tools.

Key Market Trends:

Chromatography has gained prominence in analytical chemistry due to its remarkable attributes including precise separation capabilities, reproducibility, and rapid separation processes. A significant market trend involves its widespread application in pharmaceutical contexts, such as quantifying drug compounds. The rising utilization of chromatography assays in drug validation and augmented government funding bolster the market's anticipated expansion. These factors collectively underpin the projected market growth throughout the forecast period.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Life Sciences and Analytical Instruments Market by Technology
- Market Overview
- NGS
- PCR
- Spectroscopy
- Microscopy
Global Life Sciences and Analytical Instruments Market by Application
- Market Overview
- Research applications and Clinical & diagnostic applications
Global Life Sciences and Analytical Instruments Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Agilent Technologies Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Danaher Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- PerkinElmer Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bruker Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Waters Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shimadzu Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GE Healthcare
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- bioMerieux SA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hitachi High-Technologies Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Olympus Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beckman Coulter Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eppendorf AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Illumina Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Qiagen N.V.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Becton, Dickinson and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hologic Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sartorius AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- On August 1, 2022, Thermo Fisher Scientific, Inc., a global leader in scientific services, introduced the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new network and automated microscope designed to accelerate cryo-electron tomography (Cryo-ET) research
Company Overview
Business Segment Overview
Financial Updates
Key Developments